Virtus Alternative Investment Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-83	Closed	-$11K	–	284
2020 Q3	$11K	Sell	83 -135	-62%	-$14.4K	0.2%	256
2020 Q2	$21K	Sell	218 -202	-48%	-$16.9K	0.33%	58
2020 Q1	$20K	Buy	420 +265	+171%	+$17K	0.27%	215
2019 Q4	$11K	Buy	+155	New	+$9.4K	0.17%	18

Virtus Alternative Investment Advisers's MYOK Position: Q4 2020 in Review

Virtus Alternative Investment Advisers sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 83 shares — an estimated $11K sold.

Virtus Alternative Investment Advisers first reported a position in MYOK in Q4 2019 and held it in 4 quarters. The position peaked at $21K in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Virtus Alternative Investment Advisers reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Virtus Alternative Investment Advisers sold 83 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11K.
Virtus Alternative Investment Advisers first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Virtus Alternative Investment Advisers's MyoKardia, Inc. Common Stock position peaked at $21K in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Virtus Alternative Investment Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.